HUE066045T2 - Szemészeti szuszpenzió kompozíció - Google Patents

Szemészeti szuszpenzió kompozíció

Info

Publication number
HUE066045T2
HUE066045T2 HUE22175139A HUE22175139A HUE066045T2 HU E066045 T2 HUE066045 T2 HU E066045T2 HU E22175139 A HUE22175139 A HU E22175139A HU E22175139 A HUE22175139 A HU E22175139A HU E066045 T2 HUE066045 T2 HU E066045T2
Authority
HU
Hungary
Prior art keywords
suspension composition
ophthalmic suspension
ophthalmic
composition
suspension
Prior art date
Application number
HUE22175139A
Other languages
English (en)
Inventor
Mohannad Shawer
Eric Phillips
Martin J Coffey
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55359733&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE066045(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of HUE066045T2 publication Critical patent/HUE066045T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUE22175139A 2015-01-26 2016-01-26 Szemészeti szuszpenzió kompozíció HUE066045T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562107696P 2015-01-26 2015-01-26

Publications (1)

Publication Number Publication Date
HUE066045T2 true HUE066045T2 (hu) 2024-07-28

Family

ID=55359733

Family Applications (4)

Application Number Title Priority Date Filing Date
HUE18209003A HUE048564T2 (hu) 2015-01-26 2016-01-26 Szemészeti szuszpenzió készítmény
HUE16704744A HUE041945T2 (hu) 2015-01-26 2016-01-26 Szemészeti szuszpenzió készítmény
HUE22175139A HUE066045T2 (hu) 2015-01-26 2016-01-26 Szemészeti szuszpenzió kompozíció
HUE20166312A HUE059639T2 (hu) 2015-01-26 2016-01-26 Szemészeti szuszpenzió kompozíció

Family Applications Before (2)

Application Number Title Priority Date Filing Date
HUE18209003A HUE048564T2 (hu) 2015-01-26 2016-01-26 Szemészeti szuszpenzió készítmény
HUE16704744A HUE041945T2 (hu) 2015-01-26 2016-01-26 Szemészeti szuszpenzió készítmény

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE20166312A HUE059639T2 (hu) 2015-01-26 2016-01-26 Szemészeti szuszpenzió kompozíció

Country Status (14)

Country Link
US (3) US10596107B2 (hu)
EP (5) EP4082531B1 (hu)
JP (1) JP2018507252A (hu)
KR (1) KR102538370B1 (hu)
CN (1) CN107427464B (hu)
AU (3) AU2016211745A1 (hu)
BR (1) BR112017016016B1 (hu)
CA (1) CA2975106A1 (hu)
ES (4) ES2924645T3 (hu)
HU (4) HUE048564T2 (hu)
MX (1) MX2017009699A (hu)
PL (4) PL3721868T3 (hu)
PT (2) PT4082531T (hu)
WO (1) WO2016123079A1 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018507252A (ja) * 2015-01-26 2018-03-15 ボシュ・アンド・ロム・インコーポレイテッドBausch & Lomb Incorporated 眼用懸濁組成物
US11000475B2 (en) 2015-10-16 2021-05-11 Sun Pharma Advanced Research Company Limited Ophthalmic solution of difluprednate
FI3245988T3 (fi) 2016-05-18 2024-02-22 Sonikure Holdings Ltd Järjestelmä lääkkeiden antamiseksi ultraäänivahvisteisesti kovakalvon läpi
AU2018318123B2 (en) 2017-08-15 2024-07-25 Nephron Pharmaceuticals Corporation Aqueous nebulization composition
WO2020061249A2 (en) * 2018-09-21 2020-03-26 Ps Therapies Ltd. Artificial tear, contact lens and drug vehicle compositions and methods of use thereof
JP6994061B2 (ja) * 2019-02-15 2022-01-14 ノバルティス アーゲー 4-(7-ヒドロキシ-2-イソプロピル-4-オキソ-4h-キナゾリン-3-イル)-ベンゾニトリルの製剤
EP4431497A1 (en) * 2019-02-15 2024-09-18 Bausch + Lomb Ireland Limited Crystalline forms of 4-(7-hydroxy-2-isopropyl-4-oxo-4h-quinazolin-3-yl)-benzonitrile and formulations thereof
WO2021034850A1 (en) * 2019-08-18 2021-02-25 Iview Therapeutics, Inc. In-situ gel forming ophthalmic formulations containing difluprednate
KR102271247B1 (ko) * 2020-11-04 2021-06-30 삼천당제약주식회사 안과용 현탁액 조성물의 제조방법
CN115554238A (zh) * 2022-10-25 2023-01-03 苏州欧康维视生物科技有限公司 眼用混悬液及其制备方法
CN115887372A (zh) * 2022-10-25 2023-04-04 苏州欧康维视生物科技有限公司 丙酸氟替卡松混悬液及其制备方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4996335A (en) 1980-07-10 1991-02-26 Nicholas S. Bodor Soft steroids having anti-inflammatory activity
US4540930A (en) 1983-09-12 1985-09-10 Wisconsin Alumni Research Foundation Plywheel-powered mobile X-ray apparatus
AU565354B2 (en) 1983-11-14 1987-09-10 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
NZ226171A (en) 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
IE63392B1 (en) 1988-02-08 1995-04-19 Insite Vision Inc Ophthalmic suspensions
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5124154A (en) 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
US5252318A (en) 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
CA2134376C (en) 1993-12-20 2001-10-23 Haresh G. Bhagat Combinations of polymers for use in physiological tear compositions
US5556848A (en) * 1993-12-27 1996-09-17 Senju Pharmaceutical Co., Ltd. Ophthalmic suspension containing diflupredonate
TWI227143B (en) 1999-12-15 2005-02-01 Guo-Jiun Sung In situ gel formation for ophthalmic delivery by combining Pluronic/Carbopol medic composition and its preparing method
AR033151A1 (es) * 2001-04-12 2003-12-03 Sucampo Pharmaceuticals Inc Agente para el tratamiento oftalmico topico de las enfermedades inflamatorias oculares
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
US20040258757A1 (en) * 2002-07-16 2004-12-23 Elan Pharma International, Ltd. Liquid dosage compositions of stable nanoparticulate active agents
CA2839898C (en) 2003-06-13 2017-01-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US20050197303A1 (en) 2003-10-31 2005-09-08 Bausch & Lomb Incorporated Combination of loteprednol etabonate and tobramycin for topical ophthalmic use
US20050182039A1 (en) 2004-02-13 2005-08-18 Bausch & Lomb Incorporated Use of Loteprednol etabonate for the treatment of dry eye
TWI358290B (en) 2004-12-02 2012-02-21 Alcon Inc Topical nepafenac formulations
US7919483B2 (en) 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US20070110812A1 (en) 2005-11-14 2007-05-17 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
US20120028947A1 (en) 2005-11-14 2012-02-02 Erning Xia Ophthalmic Compositions
US20100234336A1 (en) 2005-11-14 2010-09-16 Erning Xia Ophthalmic Compositions
US8846770B2 (en) * 2008-06-18 2014-09-30 Otonomy, Inc. Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
US8501800B2 (en) 2009-03-05 2013-08-06 Insite Vision Incorporated Controlled-release ophthalmic vehicles
CN101966143A (zh) 2009-07-28 2011-02-09 胡容峰 加替沙星温度及pH敏感眼用凝胶的制备与应用
ES2550942T3 (es) 2009-12-03 2015-11-13 Alcon Research, Ltd. Suspensiones de nanopartículas que contienen polímero de carboxivinilo
WO2013043387A1 (en) 2011-09-22 2013-03-28 Bausch & Lomb Incorporated Ophthalmic gel compositions
EP4008355A1 (en) 2012-05-03 2022-06-08 Kala Pharmaceuticals, Inc. Pharmaceutical nanoparticles showing improved mucosal transport
DK3517541T3 (da) 2012-05-08 2020-09-07 Nicox Ophthalmics Inc Polymorf form af fluticasonpropionat
US8765725B2 (en) * 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
KR101772263B1 (ko) 2012-05-11 2017-08-28 액티버스 파마 컴퍼니 리미티드 유기 화합물 나노분체, 그 제조 방법 및 현탁액
MX2015002208A (es) 2012-08-31 2015-05-08 Bausch & Lomb Composiciones oftalmicas con acidos grasos omega-3.
US20150190407A1 (en) 2014-01-07 2015-07-09 Insite Vision Incorporated Methods for treatment of postoperative inflammation with reduced intraocular pressure
NZ728136A (en) 2014-07-11 2017-10-27 Fujifilm Corp Method for producing aqueous ophthalmic composition, and aqueous ophthalmic composition
WO2016006702A1 (ja) 2014-07-11 2016-01-14 富士フイルム株式会社 眼科用水性組成物
JP6567648B2 (ja) 2014-07-28 2019-08-28 サン、ファーマ、アドバンスト、リサーチ、カンパニー、リミテッドSun Pharma Advanced Research Company Limited 薬物のバイオアベイラビリティーの増加および/または眼作用の持続方法
JP2018507252A (ja) * 2015-01-26 2018-03-15 ボシュ・アンド・ロム・インコーポレイテッドBausch & Lomb Incorporated 眼用懸濁組成物

Also Published As

Publication number Publication date
EP3721868A1 (en) 2020-10-14
EP3470059B1 (en) 2020-04-01
EP3721868B1 (en) 2022-06-01
WO2016123079A1 (en) 2016-08-04
US20160213609A1 (en) 2016-07-28
AU2016211745A1 (en) 2017-08-31
PL3470059T3 (pl) 2020-11-30
EP3250185A1 (en) 2017-12-06
US10596107B2 (en) 2020-03-24
CN107427464B (zh) 2022-04-05
US20200214977A1 (en) 2020-07-09
EP3470059A1 (en) 2019-04-17
ES2924645T3 (es) 2022-10-10
BR112017016016B1 (pt) 2023-12-19
HUE048564T2 (hu) 2020-08-28
HUE059639T2 (hu) 2022-12-28
KR20170105610A (ko) 2017-09-19
CA2975106A1 (en) 2016-08-04
EP4268850A1 (en) 2023-11-01
BR112017016016A2 (pt) 2018-03-20
CN107427464A (zh) 2017-12-01
US11534395B2 (en) 2022-12-27
KR102538370B1 (ko) 2023-06-01
AU2021203027A1 (en) 2021-06-10
US20230140895A1 (en) 2023-05-11
EP3250185B1 (en) 2018-12-05
ES2787039T3 (es) 2020-10-14
AU2023248145A1 (en) 2023-11-02
ES2704125T3 (es) 2019-03-14
JP2018507252A (ja) 2018-03-15
PT3721868T (pt) 2022-08-12
HUE041945T2 (hu) 2019-06-28
PL4082531T3 (pl) 2024-04-08
EP4082531A1 (en) 2022-11-02
PL3721868T3 (pl) 2022-11-07
PT4082531T (pt) 2023-12-14
ES2966595T3 (es) 2024-04-23
PL3250185T3 (pl) 2019-05-31
MX2017009699A (es) 2017-10-23
EP4082531B1 (en) 2023-10-11
AU2021203027B2 (en) 2023-07-13

Similar Documents

Publication Publication Date Title
IL249643A0 (en) Eye preparation
HK1244689A1 (zh) 水性眼科組合物
GB2556619B (en) Suspension compositions
PL3250185T3 (pl) Oftalmiczna kompozycja zawiesinowa
PL3373973T3 (pl) Kompozycje do oczu
TWI563311B (en) Eyeglasses
GB201619525D0 (en) Ophthalmic composition
SG11201707117SA (en) Ophthalmic composition
GB2570376B (en) Suspension compositions
PL3446682T3 (pl) Kompozycja okulistyczna
ZA201703701B (en) Ophthalmic composition
IL251590B (en) Ophthalmic preparations
GB2556252B (en) Suspension arrangement
PT3093169T (pt) Mecanismo de suspensão
PT3470059T (pt) Composição de suspensão oftálmica
GB201516201D0 (en) Suspension
AU201610412S (en) Sunglasses
GB201501337D0 (en) Suspension arrangement
GB201518525D0 (en) Spectacles
GB201511428D0 (en) Stabilizer
GB201514291D0 (en) Spectacles
GB201421941D0 (en) Suspension bridges
GB201421944D0 (en) Suspension bridges
GB201421938D0 (en) Suspension bridges
GB201506736D0 (en) Spectacles ect